Thymosin Alpha-1: What It Is and How It's Used in the Philippines

Quick read: Thymosin Alpha-1 is a 28-amino-acid peptide that modulates immune function by enhancing T-cell maturation and activity. Dosed at 1.6mg sub-q 2x weekly, it's used for immune support, chronic infections, and autoimmune modulation. In PH, it's used for immune support during flu season and for autoimmune considerations.

What it is

Thymosin Alpha-1 is a naturally occurring peptide produced by the thymus gland. It supports T-cell development, enhances immune response, and modulates cytokine production.

It's approved in some countries (not the US) for hepatitis B, hepatitis C, and cancer immunotherapy support.

Research shows Thymosin Alpha-1 improves immune function in immunocompromised patients and supports recovery from chronic viral infections.

In the PH peptide community, Thymosin Alpha-1 is used for immune support, especially during flu season, and by users with autoimmune conditions or chronic infections.

What it's used for

Primary use: Immune modulation and support.

Secondary use: Chronic infections (viral, bacterial).

Tertiary use: Autoimmune support (experimental).

Realistic expectations: Users report fewer infections, faster recovery from illness, improved immune resilience.

Typical protocols

Immune support protocol:

• Dose: 1.6mg sub-q, 2x weekly (e.g., Monday and Thursday)
• Duration: 4-12 weeks, or ongoing during high-risk periods (flu season)

Chronic infection protocol:

• Dose: 1.6mg sub-q, 2-3x weekly
• Duration: 8-16 weeks

What users typically report

Week 1-4: Some users report feeling more resilient to illness. Fewer colds or faster recovery.

Week 5-12: Continued immune support. Users with chronic infections report gradual improvement.

Variance: Response is individual. Users with compromised immune function tend to notice more benefit.

Common side effects

Side effects are minimal.

Injection site irritation (5%): Mild redness or swelling.

Mild fatigue (rare, <5%): Occasionally reported.

Serious side effects are not documented.

Side effect management

Injection site irritation: Rotate sites.

Fatigue: Ensure adequate sleep and nutrition.

Who this compound is for

Users seeking immune support, people with chronic infections, or users with autoimmune conditions (experimental).

Popular in PH for immune support during flu season and among users with compromised immune function.

Who this compound is NOT for

Pregnancy/breastfeeding: Limited safety data.

People with acute severe infections: Seek medical treatment first.

PH-specific considerations

Immune support during PH flu season: Thymosin Alpha-1 is used for immune resilience during rainy season (June-November) when respiratory infections peak.

Autoimmune considerations: Some PH users with autoimmune conditions run Thymosin Alpha-1 for immune modulation, though this is experimental.

Common stacks

Thymosin Alpha-1 + BPC-157: For comprehensive healing and immune support.

Thymosin Alpha-1 + TB-500: For systemic recovery and immune function.

Thymosin Alpha-1 + LL-37: For antimicrobial and immune support (advanced users).

Things to watch

Thymosin Alpha-1 doesnt require specific bloodwork. Effects are subjective.

Subjective metrics:

• Frequency of illness (colds, flu)
• Recovery time from infections
• Overall immune resilience

Coming off / cycling

Thymosin Alpha-1 can be used continuously or cycled. Many users run it during high-risk periods (flu season, travel, stress) and stop during low-risk periods.

No cycling required. No rebound immunosuppression after stopping.

Related compounds

• BPC-157 — General healing and immune support
• LL-37 — Antimicrobial peptide
• TB-500 — Systemic healing

Sources

• Goldstein 2007 — Thymosin Alpha-1 immune modulation
• Garaci 2012 — Thymosin Alpha-1 for chronic infections

Last updated: 2026-05-20. This page is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.